Browsing: advance

Co-founder Hanadie Yousef to step down as CEO as company gears up for more clinical trials of drugs designed to…

Synaffix, a Lonza company focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs), and Sidewinder…

Credit: Gorodenkoff/Getty Images Transcenta Therapeutics, a global clinical stage biopharmaceutical company, entered into a strategic collaboration and non-exclusive licensing agreement…

Northwestern researchers unveil the most detailed 3D genome maps, revealing how DNA folding regulates genes and disease risk. For decades,…

Startup targets ‘brainspan’ with EEG-powered headphones designed to make monitoring cognitive health as normal as heart rate. Consumer neurotech company…

Initial focus on epilepsy could drive progress in aging and healthspan therapeutics targeting the mTOR pathway. US biotech Aeovian Pharmaceuticals…

The event brings together leading brands, innovative suppliers, major retailers, academics and market experts to explore the biggest industry growth…

NADMED introduces a $30,000 research award to support scientists exploring the metabolic signals that shape health, aging and disease. As…

MitoRx raises new funding to advance Myo-004, a first-in-class mitochondrial-targeted obesity treatment that aims to preserve lean mass. Oxford-based biotechnology…

In a recent article in Elsevier’s International Journal of Biological Macromolecules, scientists at Vignan’s Foundation for Science, Technology, and Research…